Here's how to find the right message in life sciences

Inside: Why complex life-science technologies fall flat in marketing, and a simple framework (context, capability, consequence) for finding a message that scientists and busy buyers both understand.

Messaging & Positioning

Key takeaways

  • Context, Capability, Consequence is the structure behind Ooho's messaging framework. It starts with a familiar reference point, moves to the new ability your technology unlocks, and ends with the practical result for the people using it.
  • Life-science messages often fail because the science is right, but the story isn’t clear. This article shows how to find the message your product needs.
  • Can your buyer repeat your main message to a colleague after a webinar, in their own words? Run the water-cooler test to find out.
  • Ooho outlines five steps you can run internally before you call an agency, starting with picking one specific application.
  • Collect the two extremes on purpose. The scientist's headline and the commercial lead's headline, side by side, usually show the real messaging gap.

There's an adage in marketing: you don't sell the magic mushroom, you sell Super Mario. In other words, you lead with the outcome: the faster workflow, the higher quality, the healthier lives.

And in life sciences, that instinct often produces the same set of abstract promises everyone uses:

  • “High quality.”
  • “Fast turnaround.”
  • “Driving better outcomes.”

Nothing here is wrong, but everything sounds interchangeable. The scientific nuance disappears, and so does any differentiation.

On the other hand, when scientists shape the message, the pendulum swings the other way. The story sinks into mechanisms, modalities, assay formats and specifics that are technically accurate, but commercially unusable.

Neither group is wrong. They're optimising for different things: scientific accuracy on one side, a compelling commercial story on the other. The result is the same: a message that pleases the team internally but lands flat with the people who actually need to use it.

The messaging pendulumToo technical, too generic, and the line in betweenSame product, three headlines. Tap one to swing the message there.
Headlines from a digital PCR platform launch, as described in this article.

Why messaging is harder in life sciences

Life-science and medtech buyers aren't generic B2B personas. They're PIs, lab heads, clinical specialists, translational scientists, or scientifically-trained commercial leaders. That creates two constraints:

  • You can't dumb things down. If you strip away too much scientific detail, you lose credibility fast. Because a vague, consumer-style message doesn't help a principal investigator justify a budget or change a lab protocol.
  • But you can't bury them in mechanisms either. Everyone is busy, including scientists. They need to understand, at a glance, what the technology means for their work.

On top of that, many offerings are platforms, not single-point solutions:

  • A genomics platform might support oncology, infectious disease and wastewater monitoring.
  • An imaging system might be used in gut research, immunology and oncology.
  • A proteomics platform might span discovery research, translational studies, and clinical programmes.

One message rarely fits all. This is where many companies get stuck: they try to build a “platform-wide” narrative, and it becomes too abstract for scientists or too vague for decision-makers.

Platform messagingOne platform, one message per applicationPick an application and watch the headline sharpen.
HeadlineAdvanced genomic insights across every application.Lands withNobody in particularToo abstract to act onA line written for every application says nothing to any of them.
HeadlineDetect rare tumour variants in a blood sample, no tissue biopsy needed.Lands withTranslational oncology teamsConcreteOne application, one concrete line. Start with the one that moves revenue in the next 90 days.
HeadlineIdentify the pathogen and its resistance genes in a single run.Lands withClinical microbiology labsConcreteSame platform, a different reader, a different capability up front.
HeadlineSpot a new variant in a city’s wastewater before cases reach the clinic.Lands withPublic health surveillance teamsConcreteEach line passes the water-cooler test for its own audience.
Example lines for an illustrative genomics platform, written for this article.

Most teams then fall into one of two familiar traps: scientists lean into mechanisms, producing language that requires readers to decode what it enables, while commercial teams lean into broad promises, producing lines that could come from almost any vendor.

Your buyer is between both extremes:

  • They are scientifically literate.
  • They care about real-world applications and constraints.
  • They are too busy to reverse-engineer your point.

‍

The middle ground: capabilities that already imply outcomes

If the two extremes don't work, what does?

Across our client work, we've found that the most effective messaging in life sciences lives in a very specific place: the capability that already implies its own relevance.

Not a technical description. Not an abstract benefit, but a concrete capability that lets a scientifically literate reader fill in the implications without you spelling everything out.

Here's what this looks like in practice:

Example 1: “768 samples in a single workday”

When shaping the launch narrative for a high-throughput digital PCR platform, the internal debate covered the usual points:

  • the partitioning architecture
  • ultra-low allele frequency sensitivity
  • improved optical detection
  • the flexibility across oncology, infectious disease, and QC workflows

All scientifically valid, but none answered the real question: “What does this enable that wasn't possible before?”

The final headline was: “768 samples in a single workday.”

The capability is the storyEverything a reader hears in 768 samples in a single workdayOne number and a time frame. A lab reader adds the rest without being told.
768samplesin a single workday
What the reader fills in
01Same-day turnaround for full 96- or 384-well plates02Many experiments in parallel instead of in a queue03Full cohorts instead of sampled subsets04More statistical power for variant detection and assay validation05Fewer batching delays and bottlenecks06More output without adding headcount
None of this is written in the headline. The reader supplies it.
Launch headline for a high-throughput digital PCR platform, as described in this article.

It looks almost too simple but to the right reader, it communicates a huge amount of information instantly:

  • same-day turnaround for full 96- or 384-well plates
  • the ability to run many experiments in parallel rather than queue them
  • enough throughput to process full cohorts instead of sampling subsets
  • higher statistical power for variant detection and assay validation
  • fewer batching delays and workflow bottlenecks
  • dramatically higher productivity without adding headcount

A molecular biologist or operations lead doesn't need these benefits spelled out: they already know what 768 samples per day unlocks.

Example 2: “See food intolerances as they occur”

For an in vivo imaging technology used in gut research, the underlying innovation was in optics and engineering.

Internally, the instinct was to talk about the specifics of optical engineering or too generic marketing lines.

But when we stepped back and asked, “What does this let a clinician do that they couldn't do before?”

The answer was obvious: “See food intolerances as they occur.”

That sentence tells the right reader almost everything they need to know:

  • It's in vivo rather than ex vivo.
  • It's real-time.
  • It captures mechanistic biology at the moment of interest.
  • It opens up experiments they couldn't run before.

Again, it's still a feature, but one that makes its own implications clear.

You don't need to add “revolutionary imaging” on top. The capability itself is the revolution (and your reader knows it).

Ooho's messaging framework

Your audience is:

  • Smart enough to handle specifics, and
  • Busy, so they need clarity fast.

This is the backbone of our life science marketing strategy: a simple structure we use across all Ooho client projects, the Context → Capability → Consequence framework.

1. Context: give readers a familiar reference point

Before you say anything new, your audience needs to know: “What am I looking at?”

In life sciences, this step is non-negotiable.

If you introduce a capability too early, the reader must first guess the category, which creates friction and kills comprehension.

Context is your anchor. It can be as simple as:

  • “A digital PCR platform…”
  • “A contamination test…”
  • “An in-vivo imaging system…”

By grounding the story in something the reader already knows, you're giving their brain a shelf to put your product on before you tell them why your shelf is different.

2. Capability: the new ability your technology unlocks

Once context is clear, now you introduce the thing that actually matters: the new action the scientist or team can take that they couldn't before.

This is not a feature or mechanism. It's not “advanced something-something” or “novel X-powered Y.”

It's the simple, concrete ability you enable:

  • “Run 768 experiments in a day”
  • “Detect contamination in 10 minutes.”
  • “See food intolerances as they occur.”

A scientifically literate reader instantly understands why they matter.

3. Consequence: make the relevance unmistakable

Capabilities are powerful, but they become unforgettable when paired with the immediate consequence: the practical, first-order impact.

Not abstract outcomes like: “better insights” / “faster research” / “transforming workflow efficiency”

Instead, your consequence is the real-world shift your capability enables:

  • “Collapse multi-day runs into a single shift.”
  • “Let QC teams release batches in a single shift.”
  • “Observe causal gut biology instead of inferring it.”

These are specific, believable, immediate consequences: exactly the things scientists care about and decision-makers can act on.

Bonus: use the “water-cooler sentence”

Ask yourself: “If someone saw this webinar or opened this deck, what sentence would they say to a colleague afterwards?”

The answer is rarely: “They have an innovative platform for better insights”

It usually sounds more like:

  • “They can run 768 experiments in a day on a single digital PCR system.”
  • “They can show you food intolerances in real time, inside the gut.”
  • “They can detect contamination in under ten minutes.”

These sentences work because they hit all three parts of the messaging framework:

  • Context → digital PCR, gut imaging, contamination testing
  • Capability → 768 samples/day, real-time in-vivo readout, 10-minute QC
  • Consequence → parallel experiments, causal biology, same-day batch release

That “water-cooler sentence” becomes a practical filter: if it can't be said easily, it probably won't travel inside a customer organisation.

‍

How to improve your messaging internally (before you call an agency)

Here's a practical way to improve your messaging, even before you involve an agency.

Step 1: Pick one specific application.

Don't try to write for the entire platform at once.

Consider: Which application would move the biggest commercial needle in the next 90 days?

Step 2: Collect the two extremes on purpose.

Ask a scientist on the project team: “If you had to write one headline to explain this to a peer, what would you write?”

Ask a commercial lead: “If you had to write one headline that would get a prospect to take a meeting, what would you write?”

Write both versions down without editing. This surfaces the tension explicitly instead of letting it play out indirectly in comments.

Step 3: Rewrite as one concrete capability.

Together, look for the specific capability that sits behind both versions.

Questions that help:

  • “What is the one thing this lets our customer do that they couldn't do before?”
  • “Is there a number, constraint, or threshold that really matters to them?”
  • “How would they describe this informally to a colleague in their own lab?”

Use that to build a single, concrete line: one simple sentence, no adjectives unless they add information, no claims you wouldn't defend in a Q&A with a domain expert.

Step 4: Apply the water-cooler test.

Now ask: “If a buyer repeated this to a colleague, what would they say?”

If they'd repeat your sentence more or less verbatim, you're close.

If they'd summarise it as “some kind of faster platform with better insights”, keep iterating.

The water-cooler testWhich message survives two retellings?Switch messages and follow each one from the webinar to the lab head.
Webinar attendee, after the sessionThey have an innovative platform for better insights.They can run 768 experiments in a day on a single digital PCR system.Facts carriedA platformNo number768 a dayDigital PCROne system
Lab colleague, at the coffee machineSome kind of platform with better insights, I think.They run 768 experiments a day on one digital PCR system.Facts carriedA platformNo number768 a dayDigital PCROne system
Lab head, deciding what to do nextSo, some kind of faster platform?768 a day on one system? Let’s see it on our own assays.Facts carriedA guess: faster?768 a dayOne systemNext step: a demo
Nothing concrete reached the lab head. The message died at the coffee machine.The line arrived intact, and the lab head acted on it.
Sentences from the water-cooler test described in this article.
Step 5: Remove ink spillage.

Finally, go back through the text and strip out anything that doesn't change meaning:

  • “breakthrough”, “next-generation”, “revolutionary”, “cutting-edge” → Show don't tell!
  • Generic phrasing like “transformative insights” or “unmatched performance”

If you've done Steps 1–4 well, removing these won't hurt.

Remove ink spillageCut the words that don’t change the meaningSwitch between the draft and the edit. The reader learns the same three facts from both.
Product page, hero copyHype wordGeneric phrase

Our next-generation, cutting-edge digital PCR platform delivers transformative insights and unmatched performance: it runs 768 samples in a single workday. A revolutionary breakthrough for your lab.

Words10 of 26Hype words cut4Generic phrases cut2Meaning lostNone
The reader still knowsIt is a digital PCR platformIt runs 768 samplesIn a single workday
Example copy written for this article. Word list from Step 5.
A short, anonymised example

One genomics company we worked with had strong technology and good data, but their public-facing story read almost like a methods section.

Sales kept giving the same feedback: “People get it once I explain it but the website and deck don't help. I have to start from scratch.”

So we:

  • Went through their publications and internal material
  • Identified a small set of high-value applications
  • Reframed the top-level message
  • Built segmented decks for each application

The internal reaction was telling:

  • Scientists were relieved that the story was still technically sound.
  • Sales said that people arrived at calls with a clearer baseline understanding.
  • The marketing team had a simpler backbone to build around.

Closing

In most life science and medtech organisations, messaging friction isn't a personality conflict. It's a structural one:

  • Scientists are trying to protect the integrity of the work.
  • Commercial teams are trying to make the story legible to the market.

If you stay at either extreme, you get messages that are technically dense or too generic.

The middle ground looks like this:

  • Clear, concrete capabilities
  • Expressed at a level the buyer can immediately understand
  • Specific enough to be memorable
  • Simple enough to repeat

Get that right, and everything else gets easier: your decks and website convert faster, teams have a shared reference point, and your outreach, launches, and campaigns have a story that actually helps sales do their job.

If you're struggling to find this balance, or if internally everything feels “too technical” or “too generic”, this is the life science marketing work we do every day. Work that pays off directly in pipeline, not just in “brand feel”.

‍

Frequently asked questions

It's the three-part structure Ooho uses across client projects. Start by giving readers a familiar reference point, then name the new ability your technology unlocks, then state the practical result for the people using it.

Context comes first so the capability resonates with the right audience.

Ask a scientist and a commercial lead for one headline each. Write both down without editing them. This surfaces the tension explicitly, instead of letting it play out indirectly in comments.

Let’s get in touch.

We build brands that make your science impossible to overlook, and worth more once it’s understood. Let’s talk about your rebrand.